Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 34.18 ($0.44) and traded as low as GBX 29 ($0.38). Beximco Pharmaceuticals shares last traded at GBX 29 ($0.38), with a volume of 62,338 shares changing hands.
Beximco Pharmaceuticals Trading Down 1.7 %
The company has a debt-to-equity ratio of 14.73, a quick ratio of 0.37 and a current ratio of 1.80. The company’s 50-day moving average price is GBX 26.43 and its 200-day moving average price is GBX 34.15. The firm has a market capitalization of £129.37 million, a PE ratio of 362.50 and a beta of 0.61.
About Beximco Pharmaceuticals
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
Further Reading
- Five stocks we like better than Beximco Pharmaceuticals
- What Are Dividend Challengers?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Why Invest in 5G? How to Invest in 5G Stocks
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What Are Growth Stocks and Investing in Them
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
